PACCSC PRESENTED ABSTRACTS
←
→
Page content transcription
If your browser does not render page correctly, please read the page content below
19.02.2018
PaCCSC Presented Abstracts
Presented Abstracts
This document lists abstracts that have been presented at significant scientific and health industry
conferences in poster and oral format, both national and international.
Key:
2 x Tables for Australian conferences and International conferences
(NB: conferences held in Australia which are run by organisations that include in their title reference to
countries or regions other than Australia are included in the International conferences table)
POST = Poster presentation
ORAL = Oral presentation
LAST UPDATED: February 2018PaCCSC Presented Abstracts
No Post/Oral Abstract Title Authorship Team Members/Contributors Conference Date
National
1 ORAL Palliative Care Clinical Studies Collaborative D Currow, T Shelby-James, D Rowett, S 9th Australian Palliative Care Australia, Melbourne 2007
Whicker, J Plummer, G Gourlay, S Eckermann,
A Abernethy
2 ORAL Palliative Care Clinical Studies Collaborative David Currow Centre for Palliative Care Research & Education 2007
Conference Brisbane
3 ORAL Palliative Care Clinical Studies Collaborative – Janet Hardy Centre for Palliative Care Research & Education 2007
update on clinical studies Conference Brisbane
4 ORAL Palliative Care Clinical Studies Collaborative Currow D, Shelby-James T, Rowett D, 34th Clinical Oncological Society of Australia 2007
(PaCCSC). Plummer J, Gourlay C, Eckermann S, Adelaide November
Abernethy A
5 ORAL Evidence on efficacy, safety and cost effectivenss D Rowett, D Currow, T Shelby-James, S National Medicines Symposium, Canberra 2008
is required to inform national health policy to Eckermann, J Plummer, J Hardy, S Whicker, A
improve access to palliative care medicines Mant, A Abernethy, P Ravenscroft
6 ORAL Palliative Care Clinical Studies Collaborative T Shelby-James, D Currow, D Rowett, J 13th National Health Outcomes Conference, 2008
(PaCCSC) Plummer, G Gourlay, S Eckermann, A Canberra
Abernethy
7 ORAL Palliative Care Clinical Studies Collaborative Janet Hardy Centre for Palliative Care Research & Education 2008
Conference Brisbane
8 ORAL PaCCSC at Peter Mac Judi Greaves & Odette Spruyt Palliative Care Victoria 6th Biennial State 2008
Conference
9 ORAL High quality multi-site research in palliative care. Shelby-James T, Currow D, Hardy J, Rowett D, 10th Australian Palliative Care Australia, Perth 2009
Plummer J, Eckermann S, Bochner F
10 ORAL Designing randomised control trials of the Agar, M; Draper, B, Caplan, G, Hill, M, Shelby- 10th Australian Palliative Care Australia, Perth 2009
management of delirium in palliative care James, T, Rowett, D, Lawlor, P, Sanderson, C, Together 2009. Palliative Care Conference, Perth
inpatients. What are the challenges and way Plummer, J, Eckermann, S and Currow, D September 2009
forward?
11 ORAL Novel methodology and challenges for clinical M Agar, B Draper, D Currow, G Caplan, M Hill, 10th Australian Palliative Care Australia, Perth 2009
trials in delirium in palliative care settings C Sanderson, T Shelby-James, P Lawlor, D
Rowett
12 ORAL Palliative Care Clinical Trials Nursing: a new Annmarie Hosie 3rd Biennial Palliative Care Nurses Australia 2010
dimension of care Conference
13 POST Overview of the role of the palliative care clinical J Hunt, A Hosie, B Fazekas, J Phillips Clinical Oncological Society Australia (COSA) 2010
trials nurse within a multi-disciplinary team Conference, Melbourne
Page 2 of 19PaCCSC Presented Abstracts
No Post/Oral Abstract Title Authorship Team Members/Contributors Conference Date
National
14 ORAL A randomised, double-blind, placebo controlled, Janet Hardy, Tania Shelby-James, Meera 10th Annual Research Conference of the Centre for 2011
multi-site study of subcutaneous ketamine in the Agar, Christine Sanderson, Odette Spruyt, Palliative Care Research and Education, Brisbane
management of cancer pain. Belinda Fazekas, Simon Eckermann, John 27th May,
Plummer, Steve Quinn, David Currow,
15 ORAL A double-blind randomised controlled pilot study Presented by Janet Hardy. 11th Australian Palliative Care Conference: Cairns, 2011
of sertraline compared with placebo in people Authorship D. Currow , P. Frith, C. McDonald, 30 August – 2 September
with refractory breathlessness. K. Clark, T. Davidson , J. Plummer , H. Uronis,
A. Abernethy , M. Doogue.
16 ORAL Research methodology for multi-site research in Shelby-James T, Fazekas B, Hardy J, Currow D, 11th Australian Palliative Care Conference: Cairns, 2011
Palliative Care Clinical Studies Collaborative 30 August – 2 September
(PaCCSC) model. (Joint workshop)
17 ORAL Standardising clinical trials of cancer pain Hardy J, Shelby-James T, Fazekas B, Agar M, 11th Australian Palliative Care Conference: Cairns, 2011
management in palliative care. (Joint workshop) Spruyt O, Good P, Currow D, 30 August – 2 September
18 POST Classifying pain in cancer pain trial. Hardy J, O’Shea A, Shelby-James T, Fazekas B, 11th Australian Palliative Care Conference: Cairns, 2011
Currow D, 30 August – 2 September
19 ORAL A randomised, double-blind, placebo controlled, Janet Hardy, Tania Shelby-James, Meera 11th Australian Palliative Care Conference: Cairns, 2011
multi-site study of subcutaneous ketamine in the Agar, Christine Sanderson, Odette Spruyt, 30 August – 2 September
management of cancer pain. Belinda Fazekas, Simon Eckermann, John
Plummer, Steve Quinn, David Currow,
20 ORAL Effect of cyp2b6 genetic variability on Yibai Li, Andrew A Somogyi, Janet K Coller, ASCEPT-AUPS-HBPRCA joint meeting,4 – 9 2011
pharmacokinetics and metabolism of ketamine as Janet Hardy, David Currow, Nathan Stanley, December, Perth, Australia
a co-analgesic in chronic cancer pain patients: a Mark R Hutchinson
pilot study.
21 ORAL Prescribing at the end of life, pharmacovigilance Debra Rowett, David Currow, Belinda National Medicines Symposium 2012, Building a 2012
and palliative care. Fazekas, , Josephine Clayton, Meera Agar, medicinewise community, Sydney 24-25 May 2012
Timothy To http://www.nps.org.au/__data/assets/pdf_file/00
04/143905/Speaker_Abstracts.pdf p.76
22 ORAL A Randomised, Double-blind Placebo-controlled Janet Hardy, Stephen Quinn, Belinda Fazekas, Australian Pain Society 33rd Annual Scientific 2013
Study to Assess the Efficacy and Toxicity of John Plummer, Simon Eckermann, Meera Meeting, 17-20 March 2013, National Convention
Subcutaneous Ketamine in the Management of Agar, Odette Spruyt, Debra Rowett, David Centre, Canberra, ACT, Australia
Cancer Pain Currow
23 POST Monitoring clinical trials: improving quality. Fazekas, B. 12th Australian Palliative Care Conference, 2013
Palliative Care - Everyone's Business, Canberra
from 3 - 6 September 2013
Page 3 of 19PaCCSC Presented Abstracts
No Post/Oral Abstract Title Authorship Team Members/Contributors Conference Date
National
24 POST Audit versus actual recruitment in palliative care Cutri, N 12th Australian Palliative Care Conference, 2013
clinical trials. Palliative Care - Everyone's Business, Canberra
from 3 - 6 September 2013
25 ORAL Is community-based palliative care cost McCaffrey, N., Agar, M., Harlum, J., Karnon, J., 12th Australian Palliative Care Conference, 2013
effective? Economic evaluation of the Australian Currow, D., & Eckermann, S. Palliative Care - Everyone's Business, Canberra
Palliative Care Extended Packages at Home from 3 - 6 September 2013
(PEACH) Pilot.
26 ORAL Recruiting to clinical trials in palliative care: Fazekas, B,. Cutri, N., Devilee, L., & Currow, D. 12th Australian Palliative Care Conference, 2013
Integrating recruitment into clinical care. Palliative Care - Everyone's Business, Canberra
from 3 - 6 September 2013
27 ORAL Redefining the specialist palliative approach: McCarthy, G., Watt, J., & Le., B.H. 12th Australian Palliative Care Conference, 2013
Clinical trials, an initial experience. Palliative Care - Everyone's Business, Canberra
from 3 - 6 September 2013
28 ORAL Participating in a palliative care clinical trial: A Cutri, N., Fazekas, B., Cosic, U., & Currow, D.C. 12th Australian Palliative Care Conference, 2013
patient’s perspective. Palliative Care - Everyone's Business, Canberra
from 3 - 6 September 2013
29 ORAL A retrospective study to report the use and Byfieldt, N. , & Clark, K. 12th Australian Palliative Care Conference, 2013
tolerability of subcutaneous ranitidine infusions Palliative Care - Everyone's Business, Canberra
on an inpatient palliative care unit. from 3 - 6 September 2013
30 ORAL What impact does community-based case McCaffrey, N., Abernethy, A.P., & Currow, D. 12th Australian Palliative Care Conference, 2013
conferencing have on non-hospital resource Palliative Care - Everyone's Business, Canberra
utilisation in patients with advanced life-limiting from 3 - 6 September 2013
illness?
31 ORAL Pharmacovigilance in hospice/palliative care: Net Crawford, G., Agar, M., Quinn, S.J., Phillips, J., 12th Australian Palliative Care Conference, 2013
effect of haloperidol for delirium. Litster, C., Michael, N., Doogue, M., Rowett, Palliative Care - Everyone's Business, Canberra
D., & Currow, D. from 3 - 6 September 2013
32 ORAL A multi-site, fixed dose, parallel arm, double- Currow, D. C., Quinn, S., Hardy, J., McCaffrey, 12th Australian Palliative Care Conference, 2013
blind, randomised, placebo-controlled trial of N., Eckermann, S., Abernethy, A.P., & Clark, K. Palliative Care - Everyone's Business, Canberra
infusional octreotide or placebo with regular from 3 - 6 September 2013
parenteral ranitidine and dexamethasone in the
control of vomiting associated with malignant
bowel obstruction.
33 ORAL The longitudinal pattern of response when Currow, D.C., Quinn, S., Greene, A., Bull, J., 12th Australian Palliative Care Conference, 2013
morphine is used to treat chronic refractory Johnson, M.J., & Abernethy, A.P. Palliative Care - Everyone's Business, Canberra
dyspnoea. from 3 - 6 September 2013
Page 4 of 19PaCCSC Presented Abstracts
No Post/Oral Abstract Title Authorship Team Members/Contributors Conference Date
National
34 POST A study to explore the breadth of physical Byfieldt, N. 12th Australian Palliative Care Conference, 2013
symptoms experienced by constipated palliative Palliative Care - Everyone's Business, Canberra
care patients. from 3 - 6 September 2013
35 POST Monitoring clinical studies – improving quality. Fazekas, B. COSA’s 40th Annual Scientific Meeting, Cancer Care 2013
Coming of Age, 12-14 November 2013, Adelaide
Australia
36 POST Audit Versus Actual Recruitment in Palliative Fazekas, B. COSA’s 40th Annual Scientific Meeting, Cancer Care 2013
Care Clinical Trials. Coming of Age, 12-14 November 2013, Adelaide
Australia
37 ORAL Barriers and enablers to palliative care nurse Hosie, A, Davidson, PM, Agar, M, Lobb, E, & Palliative Care Nurses Australia Conference, 7-8th 2014
recognition and assessment of inpatients’ Phillips, J. April 2014, Sydney Australia
delirium symptoms: a qualitative study
38 ORAL Recognising, assessing and managing delirium in Agar M and Hosie A. Palliative Care Nurses Australia Conference, 7-8th 2014
palliative care populations April 2014, Sydney Australia
39 POST Monitoring clinical studies – improving quality. Fazekas, B. Cutri, N., Fazekas, B., Devilee, L, Palliative Care Nurses Australia Conference, 7-8th 2014
Litster, C., & Currow, D.C. April 2014, Sydney Australia
40 POST Predicting recruitment to clinical trials in Fazekas, B., Cutri, N., Currow, D. Palliative Care Nurses Australia Conference, 7-8th 2014
palliative care – how accurate are feasibility April 2014, Sydney Australia
audits?’ (Audit Versus Actual Recruitment in
Palliative Care Clinical Trials.)
41 POST Recruiting to clinical trials in palliative care – Cutri, N., Fazekas, B., Devilee, L, & Currow, Palliative Care Nurses Australia Conference, 7-8th 2014
integrating recruitment into clinical care. D.C. April 2014, Sydney Australia
42 ORAL Participating in palliative care clinical research: Devilee, L., Currow, D., Doogue, MP., & Palliative Care Nurses Australia Conference, 7-8th 2014
RAPID makes it easy. Rowett, D. April 2014, Sydney Australia
43 ORAL Nurse perceptions of barriers and enablers to Hosie, A, Davidson, PM, Agar, M, Lobb, E, & Delirium Clinical and Research Day, May 2014, 2014
recognition and assessment of palliative care Phillips, J Melbourne, Australia
inpatients’ symptoms of delirium: a qualitative
study
44 ORAL An international, multi-site, consecutive cohort, Urska Cosic (Clinical Nurse SA Palliative Care State Conference, 20 June 2014, 2014
post-marketing study of the real world net Research Unit, Southern Adelaide Palliative Morphettville Junction Function Centre
clinical effects of medications used in hospice Service) and Linda Devilee (National Manager,
/palliative care – RAPID pharmacovigilance in PaCCSC Research)
palliative care
Page 5 of 19PaCCSC Presented Abstracts
No Post/Oral Abstract Title Authorship Team Members/Contributors Conference Date
National
45 ORAL A systems approach to improving cancer pain Lovell, M, Luckett, Phillips, JL, Agar, M, Boyle, Cancer treatment and care innovations 2014
management F, Stubbs, J, Birch, M-R, Green, A, Marie, N, conference. Sydney, October 2014
Davidson, PM
46 ORAL Pain management can be achieved with Lovell M, Birch MR, Luckett T, Davidson P, Palliative Care NSW State conference, Sydney 2014
commitment and support Green A, Marie N, Stubbs J, Phillips J, Agar M October 2014
and Boyle F
47 ORAL Palliative care – the challenges and the dilemmas D. Currow 47th National Conference 2014
Australian Association Gerontology, Adelaide,
South Australia November, 2014
48 ORAL Cancer pain: closing the evidence-practice gap Lovel MR, Luckett T, Phillips J, Boyle F, Clinical Oncology Society of Australia, Annual 2014
Davidson PM, Stubbs J, Birch M, Spruyt O, Scientific Meeting, Melbourne, Australia, 2-3
Agar M December 2014.
49 ORAL Better prescribing - frameworks for deprescribing D. Currow 2015 Association Regulatory and Clinical 2015
and pharmacovigilance in practice. Complexities with polypharmacy, Sydney, New
South Wales May, 2015.
50 ORAL Phase III randomized double-blind controlled trial Agar M, Lawlor P, Quinn S, Draper B, Caplan Sydney Institute of Palliative Medicine (SIPM) 2015
of oral risperidone, haloperidol or placebo with G, Hill M, Rowett D, Sanderson C, Hardy J, Le Annual Symposium 2015
rescue subcutaneous midazolam for delirium B, Eckermann S, McCaffrey N, Devilee L,
management in palliative care. Fazekas B, and Currow D.
51 ORAL Recruitment in Palliative Care: Issues, Challenges Belinda Fazekas 3rd Australian Palliative Care Research Colloquium, 2015
and Strategies Melbourne, Victoria 22-23 October 2015
52 ORAL Managing Multi-Site Clinical Trials Linda Devilee and Belinda Fazekas 3rd Australian Palliative Care Research Colloquium, 2015
Melbourne, Victoria 22-23 October 2015
53 ORAL Quantitative Studies: The Way Forward for Meera Agar 3rd Australian Palliative Care Research Colloquium, 2015
Informed Consent Melbourne, Victoria 22-23 October 2015
54 ORAL Corticosteroids with opioids for cancer pain: A Eastman P, Le B. 3rd Australian Palliative Care Research Colloquium, 2015
survey of Australian and New Zealand palliative Melbourne, Victoria 22-23 October 2015
care clinicians.
55 ORAL Dyspnoea (Palliative Care and Respiratory Study D Currow MASCC/ISOO 25th Anniversary meeting, Adelaide, 2016
Groups) – Medications: opioids and steroids. 23-25 June, 2016
56 ORAL New evidence from palliative care clinical trials. L Devilee Palliative Care Queensland Conference 2016, 2016
Brisbane 3-5 November
57 ORAL Symptom burden at the end of life. K Clark Palliative Care Queensland Conference 2016, 2016
Brisbane 3-5 November
Page 6 of 19PaCCSC Presented Abstracts
No Post/Oral Abstract Title Authorship Team Members/Contributors Conference Date
National
58 ORAL Invited Speaker - Redefining Specialist Palliative B Le 5th Australian Palliative Care Research Colloquium 2017
Care
59 ORAL Invited Speaker – Research Developments in B Le Australian Association of Gerontology Webinar 2017
Palliative Care
60 ORAL Plenary speaker - End of Life Care Ethics B Le Royal Australasian College of Physicians Congress, 2017
Melbourne, 8-10 May 2017
61 ORAL Invited speaker – Effective Palliative Care in Aged B Le Palliative and Aged Care Forum, Clariden Global 2017
Care Conference
62 ORAL Keynote Address - Palliative Care Integration and B Le 3rd Victorian Integrated Cancer Services 2017
Optimal Care Conference
63 ORAL From PARHIS with love - measuring successful Phillips, J.L., Lovell, M., Agar, M.R., Boyle, F., Cancer Nurses Society of Australia 20th Annual 2017
evidence-based guideline implementation. Davidson, P.M., Luckett, T., Currow, D.C., Congress, Adelaide, SA, 15-17 June 2017.
Lam, L.T., McCaffrey, N., Shaw, T., & Read, A.
64
65
Page 7 of 19PaCCSC Presented Abstracts
No Post/Oral Abstract Title Authorship Team Members/Contributors Conference Date
International
1 ORAL Australian Palliative Care Clinical Studies T Shelby-James, D Currow, D Rowett, S 10th Congress of the European Association Pall 2007
Collaborative Whicker, J Plummer, G Gourlay, S Eckermann, Care, Budapest
A Abernethy
2 ORAL Policy development for access to priority D Rowett, A Mant, S Whicker, T Shelby-James, Pharmaceutical Policy Analysis, The Netherlands, 2007
medicines in palliative care in Australia D Currow September
3 ORAL Designing randomised controlled trial of the M Agar, B Draper, G Caplan, M Hill, T Shelby- 5th Research Forum of the European Association 2008
management of delirium in palliative care James, D Rowett, P Lawlor, C Sanderson, J Palliative Care, Trondheim
inpatients. What are the challenges and way Plummer, S Eckermann, D Currow
forward?
4 ORAL Palliative Care Clinical Studies Collaborative T Shelby-James, D Currow, D Rowett, J 5th Research Forum of the European Association 2008
(PaCCSC) Plummer, G Gourlay, S Eckermann, A Palliative Care, Trondheim
Abernethy
5 ORAL Designing randomised controlled trial of the M Agar, B Draper, G Caplan, M Hill, T Shelby- 3rd Delirium Congress Helsinki 2008
management of delirium in palliative care James, D Rowett, P Lawlor, C Sanderson, J
inpatients. What are the challenges and way Plummer, S Eckermann, D Currow
forward?
6 ORAL Designing randomised control trials of the Agar, M; Draper, B, Caplan, G, Hill, M, Shelby- European Association for palliative care research 2008
management of delirium in palliative care James, T, Rowett, D, Lawlor, P, Sanderson, C, forum, Trondheim 2008;
inpatients. What are the challenges and way Plummer, J, Eckermann, S and Currow, D.
forward?
7 ORAL Designing randomised control trials of the Agar, M; Draper, B, Caplan, G, Hill, M, Shelby- European Delirium Association Congress Helsinki 2008
management of delirium in palliative care James, T, Rowett, D, Lawlor, P, Sanderson, C, October 2008
inpatients. What are the challenges and way Plummer, J, Eckermann, S and Currow, D.
forward?
8 ORAL Palliative Care Clinical Studies Collaborative Janet Hardy Hospice NZ Annual Conference, Palmerston NZ 2009
9 ORAL A novel approach to the economic evaluation of N McCaffrey, S Eckermann International Health Economics Association 2009
pharmaceuticals iwht multiple consequences Congress Beijing China, July
under uncertainty: a theoretical application of
the net benefit correspondence theorem and
data development analysis
10 ORAL Providing infrastructure to conduct multi-site D Currow, T Shelby-James, Fazekas B, Hardy EAPC 2010, 6th Research Congress 10-12 June, 2010
research within palliative care – learnings from Glasgow, UK
the Palliative Care Clinical Studies Collaborative
(PaCCSC). Oral presentation
Page 8 of 19PaCCSC Presented Abstracts
No Post/Oral Abstract Title Authorship Team Members/Contributors Conference Date
International
11 ORAL Reporting serious adverse events (SAEs) in T Shelby-James, J Hardy, B Fazekas, D Currow EAPC 2010, 6th Research Congress 10-12 June, 2010
Palliative Care Studies Glasgow, UK
12 ORAL Research methodology for multi-site research in T Shelby-James, B Fazekas, J Hardy, D Currow EAPC 2010, 6th Research Congress 10-12 June, 2010
palliative care – The Palliative Care Clinical Glasgow, UK
Studies Collaborative (PaCCSC) model
13 ORAL Psychometric development of a single-item end- McCaffrey, N. Eckermann, S. Breaden, K. EAPC 2010, 6th Research Congress 10-12 June, 2010
of-life patient-reported outcome (EOLPRO): the Oaten, S. Briffa, M. Currow, D. Glasgow, UK
first piece of the puzzle.
14 ORAL Investigation of the criteria applied by palliative McCaffrey, N. Currow, D. EAPC 2010, 6th Research Congress 10-12 June, 2010
care journals to evaluate qualitative research. Glasgow, UK
15 ORAL Grappling with economic evaluation in palliative McCaffrey, N. Currow, D. Eckermann, S. EAPC 2010, 6th Research Congress 10-12 June, 2010
care – a promising foothold. Glasgow, UK
16 ORAL The old dog and the poor relation: informing McCaffrey, N. Karnon, J. Currow, D. EAPC 2010, 6th Research Congress 10-12 June, 2010
funding decisions in palliative care with cost- Eckermann, S. Glasgow, UK
consequence analysis in the cost-disutility plane.
17 ORAL Including carer effects in economic evaluations: McCaffrey, N. Currow, D. EAPC 2010, 6th Research Congress 10-12 June, 2010
willingness to care, a missing link? Glasgow, UK
18 ORAL Learning from experience – enabling palliative C Sanderson, J Hardy, T Shelby-James, M ANZSPM Annual Conference Adelaide 2010
care phase III studies in the Palliative Care Clinical Agar, D Currow
Studies Collaborative
19 ORAL Improving access and quality use of medicines in D Rowett, D Currow, T Shelby-James, S 3rd International conference for improving use of 2011
palliative care within national drug policy, Eckermann, J Hardy, L Weeks medicines, Alexandria, April
regulatory and funding frameworks.
20 ORAL A Randomised Multi-site, Double-blind, Parrallel Hardy J., Plummer J., Rowett D., Eckermann 12th Congress of the European Association for 2011
Arm, Dose Titrated Placebo Controlled Study of S., ShelbyJames T., Agar M., Spruyt O., Palliative Care (EAPC) Lisbon, Portugal, 18–21 May
Subcutaneous Ketamine in the Management of Fazekas B., Currow D.1 2011
Cancer Pain http://www.eapcnet.eu/LinkClick.aspx?fileticket=u
UYudpPvpzs%3d&tabid=1607
21 ORAL Do the trajectories of disturbed bowel habits K Clark. J Smith, D Currow 12th Congress of the European Association for 2011
differ over time in palliative care? Palliative Care (EAPC) Lisbon, Portugal, 18–21 May
2011
22 ORAL Achieving feasible trial design in delirium M Agar, B Draper, G Caplan, T Shelby-James, 12th Congress of the European Association for 2011
therapeutics evaluation in palliative care D Rowett, P Lawlor, C Sanderson, J Plummer, Palliative Care (EAPC) Lisbon, Portugal, 18–21 May
S Eckerman, D Currow 2011
23 ORAL Pharmacological management of anorexia D Currow, P Glare, P Martin, R Hunt, J Bauer, J 12th Congress of the European Association for 2011
Page 9 of 19PaCCSC Presented Abstracts
No Post/Oral Abstract Title Authorship Team Members/Contributors Conference Date
International
Greaves, M Tattersall, S Whicker, F Bochner, Palliative Care (EAPC) Lisbon, Portugal, 18–21 May
A Jatoi, S Eckermann 2011
24 ORAL Research Methodology for Multi-site research in T Shelby-James, Fazekas B, Hardy J, Currow D 12th Congress of the European Association for 2011
palliative care - The Palliative Care Clinical Palliative Care (EAPC) Lisbon, Portugal, 18–21 May
Studies Collaborative (PaCCSC) model 2011
25 ORAL A National and Governmental Perspective in David Currow 12th Congress of the European Association for 2011
Australia on Palliative Care Palliative Care (EAPC) Lisbon, Portugal, 18–21 May
2011
26 ORAL Providing infrastructure to conduct multi-site T Shelby-James, Fazekas B, Hardy J, 12th Congress of the European Association for 2011
research within Palliative Care - Learnings from Abernethy A, Currow D Palliative Care (EAPC) Lisbon, Portugal, 18–21 May
the Palliative Care Clinical Studies Collaborative 2011
(PaCCSC)
27 ORAL Learning from experience – enabling Palliative T Shelby-James, Fazekas B, Hardy J, Currow D 12th Congress of the European Association for 2011
Care Phase III studies. The Palliative Clinical Palliative Care (EAPC) Lisbon, Portugal, 18–21 May
studies Collaborative (PaCCSC) 2011
28 ORAL A randomised, double-blind, placebo controlled, J Hardy, M Agar, C Sanderson, O Spruyt, S Presented at the MASCC/ISOO 2011 International 2011
multi-site study of subcutaneous ketamine in the Eckermann, J Plummer, S Quinn, D Currow - Symposium June 23-25 Athens Greece
management of cancer pain on behalf of the Australian Palliative Care
Clinical Studies Collaborative (PaCCSC)
29 POST Standardising clinical trials of cancer pain J Hardy, T Shelby-James, B Fazekas, A O’Shea, Presented at the MASCC/ISOO 2011 International 2011
management in palliative care D Currow. Symposium June 23-25 Athens Greece (Poster)
30 POST Achieving Feasible trial design in delirium Agar M, B Draper, G Caplan, M Hill, T Shelby- 12th European Association for Palliative Care 2011
therapeutics evaluation in palliative care. James, D Rowett, P Lawlor, C Sanderson, J Congress, Lisbon
Plummer, Eckermann, S and D Currow.
31 POST A multisite, fixed dose, parallel arm, double- D. C. Currow, K. Clark, J. Cartmill, S. Pather, J. 2012 ASCO – American Society of Clinical Oncology 2012
blind, placebo controlled, block randomized trial Plummer, S. Eckermann, A. P. Abernethy, Annual Meeting – Collaborating to Conquer Cancer
of the addition of infusional octreotide or M. Agar, S. Quinn (Chicago) June 1-5 (Poster)
placebo to regular ranitidine and dexamethasone http://chicago2012.asco.org/LinkClick.aspx?filetick
for the evaluation of vomiting associated with et=--U-OYLsze8%3d&tabid=3122 p.84
bowel obstruction at the end of life.
32 POST A randomized, double-blind, placebo-controlled D. C. Currow, J. Hardy, S. Quinn, B. Fazekas, J. 2012 ASCO – American Society of Clinical Oncology 2012
study to assess the efficacy and toxicity of Plummer, S., Eckermann, M. Agar, O. Spruyt, Annual Meeting – Collaborating to Conquer Cancer
subcutaneous ketamine in the management of D. Rowett (Chicago) June 1-5 (Poster)
cancer pain. (Abstract #2604) http://chicago2012.asco.org/LinkClick.aspx?filetick
et=--U-OYLsze8%3d&tabid=3122 p.227
Page 10 of 19PaCCSC Presented Abstracts
No Post/Oral Abstract Title Authorship Team Members/Contributors Conference Date
International
33 ORAL A Randomised Double Blind Placebo Controlled Currow D., Clark K., Cartmill J., Craig A.S., Presented at 7th World Research Congress of the 2012
Trial of Infusional Subcutaneous Octreotide in Pather S., Plummer J., Eckermann S., Agar M., European Association for Palliative Care 7 – 9 June
the Management of Malignant Bowel Hardy J. 2012, Trondheim Norway
Obstruction in people with advanced cancer. http://www.eapcnet.eu/research2012/ p403
34 ORAL P214- Impact of CYP2B6*6 Genotype on Andrew Alexander Somogyi, Yibai Li, Janet 19th International Symposium on Microsomes and 2012
Ketamine Human Pharmacokinetics and Coller, Mark Hutchinson, Janet Hardy and Drug Oxidations & 12th European Regional ISSX
Microsomal Metabolism. David Currow. meeting (Noordwijk aan Zee, June 17-21, 2012)
35 ORAL Methodological and other lessons learned in Agar, M. Planning Meeting on Studies to UNderstand 2012
conducting a trial of antipsychotic agents in Delirium In Palliative Care Settings (SUNDIPS),
palliative care settings. Ottawa, June 23-24th
36 ORAL Prescribing in palliative medicine – off-licence, Peter Allcroft ANZSPM 4-7 September 2012, Queenstown NZ 2012
off-label or just confused.
37 ORAL A Randomised, Double-blind Placebo-controlled Janet Hardy, Stephen Quinn, Belinda Fazekas, 19th International Congress on Palliative Care - 2012
Study to Assess the Efficacy and Toxicity of John Plummer, Simon Eckermann, Meera Montreal, Canada, October 9-12, 2012
Subcutaneous Ketamine in the Management of Agar, Odette Spruyt, Debra Rowett, David http://www.palliativecare.ca/pdf/Pal_DetailedEng
Cancer Pain Currow 2012.pdf p.47
38 ORAL A Multi-site, Fixed Dose, Parallel Arm, Double- David Currow, Katherine Clark, John Cartmill, 19th International Congress on Palliative Care - 2012
blind, Placebo-controlled, Block Randomised Trial Selvin Pather, John Plummer, Simon Montreal, Canada, October 9-12, 2012
of the Addition of Infusional Octreotide or Eckermann, Stephen Quinn, Amy Abernethy, http://www.palliativecare.ca/pdf/Pal_DetailedEng
Placebo to Regular Ranitidine and Meera Agar 2012.pdf p.35
Dexamethasone for the Evaluation of Vomiting
Associated with Bowel Obstruction at the End of
Life.
39 POST Does the End-of-Life Patient-reported Outcome McCaffrey N. (Australia), Skuza P. (Australia), EAPC 2013, 13th World Congress 30 May to 2 June, 2013
Measure (EOLPRO) Plug the Quality of Life Eckermann S. (Australia), Breaden K. Prague, Czech Republic.
Assessment Gap? (Australia), Oaten S. (Australia), Hardy J. http://www.congressinfo.org/filerun/weblinks/?id
(Australia), Briffa M. (Australia), Currow D. =6cd67d9b6f0150c77bda2eda01ae484c&filename
(Australia) =EAPC_Final%20Program_webversion.pdf
40 POST Individualised, Community-based, End-of-Life McCaffrey N. (Australia), Agar M. (Australia), EAPC 2013, 13th World Congress 30 May to 2 June, 2013
Care Reduces Hospital Use, but at what Cost? Harlum J. (Australia), Karnon J. (Australia), Prague, Czech Republic.
Currow D. (Australia), Eckermann S. http://www.congressinfo.org/filerun/weblinks/?id
(Australia) =6cd67d9b6f0150c77bda2eda01ae484c&filename
=EAPC_Final%20Program_webversion.pdf
Page 11 of 19PaCCSC Presented Abstracts
No Post/Oral Abstract Title Authorship Team Members/Contributors Conference Date
International
41 POST The Clinical and Social Dimensions of Prescribing Breaden K. (Australia), Currow D. (Australia), EAPC 2013, 13th World Congress 30 May to 2 June, 2013
Home Oxygen for the Relief of Refractory Phillips J. (Australia), Agar M. (Australia), Prague, Czech Republic.
Dyspnoea Abernethy A. (Australia), Grbich C. (Australia) http://www.congressinfo.org/filerun/weblinks/?id
=6cd67d9b6f0150c77bda2eda01ae484c&filename
=EAPC_Final%20Program_webversion.pdf
42 ORAL Delirium at the End of Life: EAPC Early Researcher Award Lecture Meera EAPC 2013, 13th World Congress 30 May to 2 June, 2013
Developing the Evidence Base? Agar, Australia Prague, Czech Republic.
http://www.congressinfo.org/filerun/weblinks/?id
=6cd67d9b6f0150c77bda2eda01ae484c&filename
=EAPC_Final%20Program_webversion.pdf
43 ORAL A novel approach to the economic evaluation of McCaffrey, N. Karnon, J. Currow, D. 9th World Congress on Health Economics: 2013
pharmaceuticals with multiple consequences Eckermann, S. Celebrating Health Economics. International Health
under uncertainty: a theoretical application of Economics Association Conference, 7-10 July 2013,
the net benefit correspondence theorem and Sydney Australia
data envelopment analysis.
44 ORAL Improving prescribing at the end of life D Currow Indian Association of Palliative Care Annual 2014
Conference (IAPCON), Hyderabad, India
February 2014
45 ORAL Integration of palliative care into other settings: D. Currow Indian Association of Palliative Care Annual 2014
palliative care and chronic obstructive pulmonary Conference (IAPCON), Hyderabad, India
disease (COPD) - Improving prescribing at the February, 2014
end of life
46 ORAL Interdisciplinary Management of Delirium in Hosie, AM., Phillip s, JL., Agar, M., Bush, S., American Delirium Society’s (ADS) 4th Annual 2014
Palliative Care: Collaboratively Building the and Weickman, M. Meeting - Delirium: From Molecules to Clinical
Evidence Base Implementation, June 1-3, 2014 at the Embassy
Suites, Baltimore Maryland,
47 ORAL Randomised Control Trial of Oral Risperidone, Agar M.R., Lawlor P., Draper B., Caplan G., Hill 8th World Research Congress of the EAPC, Lleida 2014
Oral Haloperidol, and Oral Placebo with Rescue M., Rowett D., Sanderson C., Quinn S., Spain 5-7 June 2014
Subcutaneous Midazolam in the Management of Eckermann S., McCaffrey N., Devilee L.
Delirium in Palliative Care Inpatients Fazekas B., Currow D. Palliative Care Clinical
Studies Collaborative
48 ORAL Developing research methodologies that can D. Currow 8th World Research Congress of the EAPC, Lleida 2014
reliably examine the quality of end of life care. Spain 5-7 June 2014
49 ORAL What are the most relevant indicators to classify D. Currow 8th World Research Congress of the EAPC, Lleida 2014
a palliative care population for quality assurance Spain 5-7 June 2014
and research?
Page 12 of 19PaCCSC Presented Abstracts
No Post/Oral Abstract Title Authorship Team Members/Contributors Conference Date
International
50 POST A Study to Define the Physical Symptoms K. Clark 8th World Research Congress of the EAPC, Lleida 2014
Experienced by Constipated Palliative Care Spain 5-7 June 2014
Patients and the Impact of these Symptoms on
Quality of Life
51 ORAL An Analytic framework for delirium research in Lawlor P, Davis D, Ansari M, Hosie A, Kanji S, 8th World Research Congress of the EAPC, Lleida 2014
palliative care settings: integrated Momoli F, Bush S, Watanabe S, Currow D, Spain 5-7 June 2014
epidemiological, clinician-researcher, and Gagnon B, Agar M, Bruera E, Meagher D, De
knowledge user perspectives. Rooij S, Adamis D, Caraceni A, Marchington K,
Stewart D
52 ORAL The management of bowel obstruction related to D. Currow Sapporo Conference for Palliative and Supportive 2014
cancer or its treatments Care in Cancer, Sapporo, Japan July 2014
53 ORAL Evidence-based management of dyspnoea D. Currow Sapporo Conference for Palliative and Supportive 2014
Care in Cancer, Sapporo, Japan July 2014
54 POST Palliative Care Nurse Perceptions of Barriers and Hosie, A, Davidson, PM, Agar, M, Lobb, E, & 4th Annual Meeting of the American Delirium 2014
Enablers to Recognition and Assessment of Phillips, J Society, 2014, Baltimore, United States.
Patients’ Delirium Symptoms: A Qualitative Study
55 ORAL Progress in the pharmacological management of D Currow Breathlessness Research Interest Group (BRIG), 2014
refractory breathlessness Cambridge, England, November 2014.
56 ORAL The economic case for palliative care D Currow World Cancer Leaders’ Summit, Melbourne, 2014
Australia December 2014
57 ORAL Solving the jigsaw puzzle of refractory D. Currow 22nd Annual Conference of the American 2015
breathlessness Association of Hospice and Palliative Medicine
(AAHPM), Philadelphia, Pennsylvania, USA
February, 2015
58 ORAL Opioid errors in cancer and palliative care: Heneka, N., Shaw, T., Rowlett, D., & Phillips, International Forum on Quality and Safety in 2015
Findings from a systematic review J.L. Health Care, London, UK, 22-24 April 2015
59 ORAL Pharmacological management of refractory D. Currow Cicely Saunders International 2015
breathlessness – the evidence International Breathlessness Conference:
developing treatments for breathlessness,
Copenhagen, Denmark, May, 2015
60 POST Phase III randomized double-blind controlled trial Agar M, Lawlor P, Quinn S, Draper B, Caplan American Geriatric Society Annual Meeting, 2015
of oral risperidone, haloperidol or placebo with G, Hill M, Rowett D, Sanderson C, Hardy J, Le National Harbor USA, May 2015.
rescue subcutaneous midazolam for delirium B, Eckermann S, McCaffrey N, Devilee L,
management in palliative care. Fazekas B, and Currow D.
Page 13 of 19PaCCSC Presented Abstracts
No Post/Oral Abstract Title Authorship Team Members/Contributors Conference Date
International
61 ORAL Pharmacological management of refractory D Currow International Breathlessness Conference: 2015
breathlessness - the evidence developing treatments for breathlessness,
Copenhagen, Denmark, May 2015
62 ORAL The reality of research in hospice and palliative D Currow 11th Annual Advanced Learning in Palliative 2015
care Medicine Conference, Calgary, Canada
May 2015
63 ORAL Measuring Cancer Systems’ performance. D Currow National Cancer Research Institute Conference, 2015
System-wide improvement of outcomes – the Liverpool, England November 2015
role of data in the future
64 ORAL Palliating breathlessness – the evidence D Currow 4th Emirates Oncology Conference, Abu Dhabi, 2015
United Arab Emirates, November 2015
65 ORAL Phase III randomized double-blind controlled trial Agar M, Lawlor P Quinn S, Draper B, Caplan G, American Delirium Society 2016 Annual 2016
of oral risperidone, haloperidol or placebo with Rowett D, Sanderson C, Hardy J, Le B, Conference, Nashville, USA 3 June, 2016.
rescue subcutaneous midazolam for delirium Eckermann S, McCaffrey N, Devilee L, Fazekas
management in palliative care. B, Hill M, Currow D.
66 ORAL Phase III randomized double-blind controlled trial Agar M, Lawlor P Quinn S, Draper B, Caplan G, Oral Presentation, 9th World Research Congress, 2016
of oral risperidone, haloperidol or placebo with Rowett D, Sanderson C, Hardy J, Le B, European Association for Palliative Care, Dublin
rescue subcutaneous midazolam for delirium Eckermann S, McCaffrey N, Devilee L, Fazekas June 9-11 2016
management in Palliative Care. B, Hill M, Currow D.
67 ORAL Opioids and anxiolytics for refractory dyspnoea. D Currow International Conference on Respiratory 2016
Pathophysiology, Sleep and Breathing
Rome, Italy – June 15-17, 2016
68 POST A phase III, multi-site, randomised, double blind, D Currow Dyspnea 2016 in Paris, International Dyspnea 2016
placebo controlled parallel arm study of daily Society, The European Respiratory Society
extended release (ER) morphine for chronic Paris 16-17 June, 2016
breathlessness
69 ORAL The management of refractory dyspnoea as a D Currow Dyspnea 2016 in Paris, International Dyspnea 2016
human right. Society, The European Respiratory Society
Paris 16-17 June, 2016
70 ORAL Chronic breathlessness: a new clinical syndrome. D Currow Dyspnea 2016 in Paris, International Dyspnea 2016
Society, The European Respiratory Society
Paris 16-17 June, 2016
Page 14 of 19PaCCSC Presented Abstracts
No Post/Oral Abstract Title Authorship Team Members/Contributors Conference Date
International
71 ORAL A phase III, multi-site, randomised, double blind, D Currow European Respiratory Society 2016
placebo controlled parallel arm study of daily ERS International Meeting London 3-7 September
extended release (ER) morphine for chronic
breathlessness
72 POST Physicians’ Attitudes to Dyspnoea Management Natasha Smallwood, David Currow, Sara European Respiratory Society 2016
in Advanced Chronic Obstructive Pulmonary Booth, Anna Spathis, Louis Irving, Jennifer ERS International Meeting London 3-7 September
Disease Philip
73 ORAL Palliative Care Clinical Studies Collaborative M Lovell 22nd Hospice NZ Palliative Care Conference, 2016
(PaCCSC) – Achieving improved care of palliative Auckland, New Zealand, 14-16 September, 2016
care patients through clinical studies to inform
the quality use of medicines.
74 ORAL A qualitative exploration of patient and carer W Muircroft Round the clock: Making 24/7 palliative care a 2016
perspectives on pancreatic exocrine insufficiency reality, a joint meeting between Marie Curie and
due to pancreatic cancer the Palliative Care Section of the Royal Society of
Medicine, London, 19 October
75 ORAL A phase III, multi-site, randomised, double blind, D Currow 21st International Congress on Palliative Care 2016
placebo controlled parallel arm study of daily Montreal, Canada 18-21 October, 2016
extended release (ER) morphine for chronic
breathlessness
76 ORAL MDT v non-MDT care in lung cancer: does co- Stone, E., Rankin, N., Bewes, T., Kerr, S., Thoracic Society of Australia and New Zealand 2017
morbidity status have an impact? Phillips, J.L., Fong, K., Currow, D.C., & Shaw, T. Annual Scientific Meeting, Canberra, ACT, 25-28
March 2017.
77 POST Respiratory nurses’ knowledge and practice Disler, R., Cui, Y., Luckett, T., Smith, T., Thoracic Society of Australia and New Zealand 2017
behaviours in COPD-related advance care Donesky, D., Irving, L., Currow, D.C., Horsfall, Annual Scientific Meeting, Canberra, ACT, 24-28
planning: preliminary findings from a cross- L., & Smallwood, N. March 2017.
sectional survey study
78 POST Palliative care nurses’ attitudes and perceived Disler, R., Cui, Y., Luckett, T., Smith, T., Thoracic Society of Australia and New Zealand 2017
barriers to COPD-related advance care planning: Donesky, D., Irving, L., Currow, D.C., Horsfall, Annual Scientific Meeting, Canberra, ACT, 24-28
preliminary findings from a cross-sectional survey L., & Smallwood, N. (2017). March 2017.
study.
79 ORAL Why we are not applying what we know? D C Currow Innovative Approaches to Optimal Cancer Care in 2017
Canada Conference, Toronto, Canada, 7-8 April
2017.
80 POST Construct validation of a palliative care needs Johnson, M., Allgar, V., Chen, H., Richfield, E., European Association for Palliative Care 15th World 2017
assessment tool for use in primary care. Currow D.C. & Macleod, U. Congress, Madrid, Spain, 18-20 May 2017.
Page 15 of 19PaCCSC Presented Abstracts
No Post/Oral Abstract Title Authorship Team Members/Contributors Conference Date
International
81 POST Efficacy of melatonin to prevent delirium in Lawlor, P., Bush, S., McNamara-Kilian, M., European Association for Palliative Care 15th World 2017
advanced cancer: Feasibility of a double blind, Momoli, F., Tierney, S., Lacaze-Masmonteil, Congress, Madrid, Spain, 18-20 May 2017.
randomised, controlled trial. N., Dasgupta, M., Agar, M.R., Periera, J., &
Currow, D.C.
82 POST The Real World Effects of Prescribing in Palliative L Devilee European Association for Palliative Care 15th World 2017
Care - RAPID Congress, Madrid, Spain, 18-20 May 2017.
83 ORAL Health-related Quality of Life in Patients with N McCaffrey European Association for Palliative Care 15th World 2017
Inoperable Malignant Bowel Obstruction: Congress, Madrid, Spain, 18-20 May 2017.
Secondary Endpoint from the Double-blind,
Placebo-controlled Randomised Trial of
Octreotide
84 ORAL A Phase III, Multi-site, Randomised, Double Blind, D Currow (one of the three highest ranked European Association for Palliative Care 15th World 2017
Placebo Controlled Parallel Arm Study of Daily submitted abstracts. Invitation to present Congress, Madrid, Spain, 18-20 May 2017.
Extended Release (ER) Morphine for Chronic paper as an Oral presentation as part of a
Breathlessness Plenary session)
85 ORAL What Aspects of Quality of Life Are Most N McCaffrey European Association for Palliative Care 15th World 2017
Important from Palliative Care Patients´ Congress, Madrid, Spain, 18-20 May 2017.
Perspectives? A Systematic Review and
Framework Analysis of Qualitative Interviews
86 ORAL The use of benzodiazepines in a specialist Collier, A., Ward, P., Clark, K., Mccaffrey, N., European Association for Palliative Care 15th World 2017
palliative care unit: A focused ethnography study. Phillips, J.L., Currow, D.C., Kelly, B., & Waller, Congress, Madrid, Spain, 18-20 May 2017.
A.
87 ORAL A Phase III, multi-site, randomised, double blind, Currow, D.C., Ekstrom, M., Fazekas, B., European Association for Palliative Care 15th World 2017
placebo controlled parallel arm study of daily Plummer, J., Quinn, S., McDonald, C., Agar, Congress, Madrid, Spain, 18-20 May 2017.
extended release (ER) morphine for chronic M.R., Clark, K., Eckermann, S., & Abernethy,
breathlessness. (Winner, Best Abstract) A.
88 ORAL A new syndrome of chronic breathlessness: Johnson, M. & Currow, D.C. European Association for Palliative Care 15th World 2017
Implications for services, research, and health Congress, Madrid, Spain, 18-20 May 2017.
policy.
89 POST Palliative care nurses’ attitudes and perceived Disler, R., Cui, Y., Luckett, T., Smith, T., American Thoracic Society, Washington DC, USA, 2017
barriers to COPD-related advance care planning: Donesky, D., Irving, L., Currow, D.C., Horsfall, 19-24 May 2017.
preliminary findings from a cross-sectional survey L., & Smallwood, N.
study.
Page 16 of 19PaCCSC Presented Abstracts
No Post/Oral Abstract Title Authorship Team Members/Contributors Conference Date
International
90 POST Respiratory nurses’ knowledge and practice Disler, R., Cui, Y., Luckett, T., Smith, T., American Thoracic Society, Washington DC, USA, 2017
behaviours in COPD-related advance care Donesky, D., Irving, L., Currow, D.C., Horsfall, 19-24 May 2017.
planning: preliminary findings from a cross- L., & Smallwood, N. (2017).
sectional survey study.
91 POST Respiratory patient experiences in self-managing Disler, R., Luckett, T., Phillips, J.L., Johnson, American Thoracic Society, Washington DC, USA, 2017
emergency department 'near-miss' for M., Garcia, M., Bhattarai, P., Hutchinson, A., 19-24 May 2017.
breathlessness: A strengths-based qualitative Currow, D.C., Carrieri-Kohlman, V., Whelan,
study. B., Newton, P.J., Agar, M.R., Chye, R.,
Sheehan, C., Ivynian, S., & Davidson, P.M.
92 ORAL A randomised phase 3 trial of early referral to Mileshkin, L., Yoong, J., Nowak, A., Philip, J., American Society of Clinical Oncology Annual 2017
palliative care for patients with advanced Le, B., Agar, M.R., Phillips, J.L., Goodall, S., Meeting, Chicago, USA, 2-6 June 2017.
thoracic malignancies: The PEARL study. Schofield, P., Ulgade, A., Ball, D., Currow, D.C,
Stubbin, I., Temel, J., Clark, K., Lorgelly, P.,
Donoghoe, M., Tognela, A., Livingstone, A., &
Stockler, M.
93 ORAL Management of malignant bowel obstruction. D C Currow Sapporo Conference for Palliative and Supportive 2017
Care in Cancer, Sapporo, Japan, 16-17 June 2017.
94 POST Pooled analysis of two phase III trials: body Currow, D.C. Temel, J. S., Abernethy, A. P., Multinational Association of Supportive Care in 2017
weight response with anamorelin in advanced Friend, J., & Giorgino, R. Cancer Annual Conference, Washington DC, USA,
non-small cell lung cancer (NSCLC) patients with 22-24 June 2017.
anorexia / cachexia,
95 ORAL The impact of cancer cachexia upon the quality W Muircroft MASCC/ISOO Annual Meeting on Supportive Care 2017
of life of patients and carers in advanced in Cancer 22.24 June, 2017 Washington DC USA
pancreatic cancer – A qualitative study.
96 ORAL Inter-rater agreement between palliative care K Clark MASCC/ISOO Annual Meeting on Supportive Care 2017
clinicians when evaluating abdominal in Cancer 22.24 June, 2017 Washington DC USA
radiographs to quantify the degree of faecal
shadowing visible.
97 ORAL Preliminary site evaluation of the stop cancer Phillips, J.L., Lovell, M., Agar, M.R., Boyle, F., International Conference on Cancer Nursing, 2017
pain trial using the PARIHS framework. Davidson, P.M., Luckett, T., Currow, D.C, Lam, Anaheim, USA, 9-12 July 2017.
L.T., McCaffrey, N., Shaw, T., & Read, A.
98 ORAL Measuring what counts: impact, benchmarking D C Currow Asia Pacific Hospice Conference, Singapore, 26-29 2017
and policy. July 2017.
99 ORAL The evidence for opioids in chronic D C Currow Asia Pacific Hospice Conference, Singapore, 26-29 2017
breathlessness – are we convinced yet? July 2017.
Page 17 of 19PaCCSC Presented Abstracts
No Post/Oral Abstract Title Authorship Team Members/Contributors Conference Date
International
100 ORAL Medicinal cannabis use and preferred mode of Phillips, J.L., Luckett, T., Agar, M.R., Chye, R., Sigma Theta Tau International 28th Nursing 2017
administration: A patient survey. Lintzeris, N., Mcgregor, I., Allsop, D., Noble, Research Congress, Dublin, Ireland, 27-31 July
B., Clark, K., Lovell, M., Lee, J., Martin, P., 2017.
Sheehan, C., Aggarwal, R., Pene, C., Solowij,
N., Martin, J., Devilee, L., & Currow, D.C.
101 ORAL Good clinical governance in cancer care. D C Currow International Society of Oncology Pharmacy 2017
Professionals Australasian Symposium, 26-27
August 2017, Melbourne, VIC.
102 ORAL Invited speaker – Effective Palliative Care in Aged B Le Palliative and Aged Care Forum, Clariden Global 2017
Care Conference
103 ORAL A randomised, open label study of guideline J Hardy, H Skerman, K Franzen, K Foster, P ESMO 2017
driven targeted antiemetic therapy versus single Yates.
agent antiemetic therapy (Nausea 1 Study)
104 POST A randomised, controlled, double blind study of J Hardy, H Skerman, K Franzen, P Yates ESMO 2017
oral methotrimeprazine versus oral haloperidol
in patients with cancer and nausea not related to
anticancer therapy (Nausea 3 Study)
105 ORAL A phase II cluster randomised controlled trial of a Hosie, A., Phillips, J., Kochovska, S., Brassil, 10th World Research Congress of the EAPC, 2017
multi-component non-pharmacological M., Noble, B., Kurrle, S., Cumming, A., Caplan, October 2017
intervention to prevent delirium for hospitalised G.A., Chye, R., Le, B., Ely, E.W., Lawlor, P.G.,
people with advanced cancer: study protocol. Bush, S.H., Davis, J.M, Lovell, M., Brown, L.,
Fazekas, B., Cheah, S.L. Edwards, L. and Agar,
M,
106 POST Multicomponent non-pharmacological Hosie, A., Phillips, J., Kochovska, S., Brassil, Palliative Care Nurses New Zealand Conference 2017
intervention to prevent delirium for hospitalised M., Noble, B., Kurrle, S., Cumming, A., Caplan, 2017, October 9-10, Wellington, NZ (Poster)
people with advanced cancer: a phase II cluster G.A., Chye, R., Le, B., Ely, E.W., Lawlor, P.G.,
randomised waitlist controlled trial. Bush, S.H., Davis, J.M, Lovell, M., Brown, L.,
Fazekas, B., Cheah, S.L. Edwards, L. and Agar,
M,
107 ORAL Palliative care, surgery and palliative surgery. Currow, D.C. Annual Australasian Symposium of Perioperative 2017
Three worlds collide? Medicine, Sydney, NSW, 2-4 November 2017.
108 ORAL Gaps and the need for evidence-based research Currow, D.C. International Palliative Care Network Conference, 2017
in hospice / palliative care. online, 15 November - 15 December 2017.
Page 18 of 19PaCCSC Presented Abstracts
No Post/Oral Abstract Title Authorship Team Members/Contributors Conference Date
International
109 ORAL Invited Speaker – Overcoming Barriers to Clinical B Le Australia-Japan Palliative Care Trials Symposium 2017
Trials Japan Organisation for Research and Treatment of
Cancer and Palliative Care Clinical Studies
Collaborative 18 November 2017
110 POST Lidocaine (Lignocaine) for neuropathic cancer J Lee 2018 Australian Pain Society 38th and New Zealand 2018
pain – feasibility study protocol. Pain Society Conjoint Annual Scientific Meeting,
International Convention Centre, Sydney, 8 - 11
April 2018.
Page 19 of 19You can also read
